Heat Biologics Inc (HTBX) - Financial and Strategic SWOT Analysis Review

  • ID: 4281546
  • SWOT Analysis
  • 46 pages
  • GlobalData
  • Heat Biologics Inc
1 of 5

FEATURED COMPANIES

  • Celgene Corp
  • Chimerix Inc
  • Genentech Inc
  • Guided Therapeutics Inc
  • Intrexon Corp
  • Juno Therapeutics Inc
  • MORE
Heat Biologics Inc (HTBX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Heat Biologics Inc (Heat Biologics) is a biopharmaceutical company which develops novel immuno therapeutics for the treatment of cancer. Its pipeline encompasses viagenpumatucel-L based investigational candidate targeted at the treatment of non-small cell lung cancer, and co-stimulatory antibodies targeted at hematologic malignancies, and other tumors. The co-stimulatory antibodies harness human body's natural antigen specific immune response to reprogram the immune system to offer durable clinical outcomes. Heat Biologics’ off-the-shelf therapies are based on its proprietary T-cell activating platform (TCAP), which turns immunologically cold tumors hot. It has subsidiaries in the US, Germany, and Australia. Heat Biologics is headquartered in Durham, North Carolina, the US.

Heat Biologics Inc Key Recent Developments

Feb 28, 2018: Heat Biologics Reports Fiscal Year 2017 Financial Results
Feb 28, 2018: Heat Biologics and Its Pelican Therapeutics Subsidiary Appoint Anthony Tolcher, M.D., FRCPC, FACP to their Scientific Advisory Boards
Nov 13, 2017: Heat Biologics Reports Third-quarter 2017 Results and Corporate Update
Nov 11, 2017: Heat Biologics Presents Follow-up Data on its ComPACT T-cell Stimulating Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 06, 2017: Heat Biologics to Present Data on its ComPACT Technology, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Celgene Corp
  • Chimerix Inc
  • Genentech Inc
  • Guided Therapeutics Inc
  • Intrexon Corp
  • Juno Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Heat Biologics Inc - Key Facts
  • Heat Biologics Inc - Key Employees
  • Heat Biologics Inc - Key Employee Biographies
  • Heat Biologics Inc - Major Products and Services
  • Heat Biologics Inc - History
  • Heat Biologics Inc - Company Statement
  • Heat Biologics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Heat Biologics Inc - Business Description
  • R&D Overview
  • Heat Biologics Inc - Corporate Strategy
  • Heat Biologics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Heat Biologics Inc - Strengths
  • Heat Biologics Inc - Weaknesses
  • Heat Biologics Inc - Opportunities
  • Heat Biologics Inc - Threats
  • Heat Biologics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Heat Biologics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 28, 2018: Heat Biologics Reports Fiscal Year 2017 Financial Results
  • Feb 28, 2018: Heat Biologics and Its Pelican Therapeutics Subsidiary Appoint Anthony Tolcher, M.D., FRCPC, FACP to their Scientific Advisory Boards
  • Nov 13, 2017: Heat Biologics Reports Third-quarter 2017 Results and Corporate Update
  • Nov 11, 2017: Heat Biologics Presents Follow-up Data on its ComPACT T-cell Stimulating Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
  • Nov 06, 2017: Heat Biologics to Present Data on its ComPACT Technology, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
  • Oct 30, 2017: Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its $15.2 Million CPRIT Grant Award
  • Oct 23, 2017: Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards
  • Jul 03, 2017: Dr. Jeff Hutchins Appointed Chief Operating Officer for Heat Biologics
  • Jul 03, 2017: Heat Biologics Appoints Damien Hallet as Vice President of CMC Development
  • May 11, 2017: Heat Biologics Provides Business and Clinical Update for the First Quarter of 2017
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Heat Biologics Inc, Key Facts
  • Heat Biologics Inc, Key Employees
  • Heat Biologics Inc, Key Employee Biographies
  • Heat Biologics Inc, Major Products and Services
  • Heat Biologics Inc, History
  • Heat Biologics Inc, Subsidiaries
  • Heat Biologics Inc, Key Competitors
  • Heat Biologics Inc, Ratios based on current share price
  • Heat Biologics Inc, Annual Ratios
  • Heat Biologics Inc, Annual Ratios
  • Heat Biologics Inc, Interim Ratios
  • Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Heat Biologics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Heat Biologics Inc, Performance Chart (2013 - 2017)
  • Heat Biologics Inc, Ratio Charts
  • Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Heat Biologics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Chimerix Inc
  • Sanofi
  • Genentech Inc
  • Intrexon Corp
  • MedImmune LLC
  • Juno Therapeutics Inc
  • Guided Therapeutics Inc
  • Celgene Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll